Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 17/20 | 0.49 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.47 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4066048 | 0.91 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4065915 | 0.88 | KCNH2 (0.52) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4065674 | 0.85 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL4066049 | 0.85 | KCNH2 (0.43) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4067923 | 0.83 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL2947398 | 0.82 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4074247 | 0.81 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4071573 | 0.80 | KCNH2 (0.63) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4062218 | 0.78 | SLC2A1 (0.47) | KCNH2 | |
| Hydrochloric Acid SCHEMBL6080023 | 0.78 | KCNH2 (0.67) | KCNH2KCNQ1CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1605938-B1 | Antibacterial derivatives of napthydrin and quinoline | GLAXO GROUP LTD (GB) | 2009-02-11 | — | — | EP | claimed |
| US-20060189601-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-08-24 | — | — | US | claimed |
| EP-1605938-B1 | Antibacterial derivatives of napthydrin and quinoline | GLAXO GROUP LTD (GB) | 2009-02-11 | — | — | EP | disclosed |
| US-20060189601-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189601-A1 | Antibacterial agents | NQO2, NRDC, IFNG | KCNH2 3365/4885KCNQ1 1816/4885CACNA1C 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.